1.McIntyre, P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1993–1998. Communicable Diseases Intelligence 2000; 24: S1–S83.
2.Public Health Committee, National Health and Medical Research Council. Surveillance Case Definitions. Canberra, Australia: Australian Government Publishing Services, 1994.
3.Menzies, R, Wang, H, McIntyre, P. Has pertussis increased in New South Wales over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988–2002. New South Wales Public Health Bulletin 2003; 14: 71–76.
4.de Melker, HE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. Journal of Clinical Microbiology 2000; 38: 800–806.
5.Giammanco, A, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 2003; 22: 112–120.
6.Pebody, RG, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiology and Infection 2004; 133: 159–171.
7.Nardone, A, et al. Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine 2004; 22: 1314–1319.
8.Cagney, M, et al. The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiology and Infection 2006; 134: 1208–1216.
9.Torvaldsen, S, McIntyre, P. Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatric Infectious Diseases Journal 2003; 22: 956–959.
10.Quinn, HE, McIntyre, PB. Pertussis epidemiology in Australia over the decade 1995–2005 – trends by region and age group. Communicable Diseases Intelligence 2007; 31: 205–215.
11.National Health and Medical Research Council. The Australian Immunisation Handbook, 9th edn.Canberra, Australia: Australian Government Department of Health and Ageing, 2008.
12.Brotherton, J, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence 2007; 31: S1–S152.
13.Gidding, H. Australia's national serosurveillance program. New South Wales Public Health Bulletin 2003; 14: 90–93.
14.Kelly, H, et al. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 3130–3136.
15.Giammanco, A, et al. Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. Vaccine 2003; 21: 1924–1931.
16.Deeks, S, et al. Failure of physicians to consider the diagnosis of pertussis in children. Clinical Infectious Diseases 1999; 28: 840–846.
17.Horby, P, et al. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiology and Infection 2005; 133: 229–236.
18.Australian Bureau of Statistics. Children's immunisation Australia. Canberra: AGPS, 1995 (catalogue no. 4352.0).
19.Brotherton, J, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2001–2002. Communicable Diseases Intelligence 2004; 28: S1–S116.